Document is current
Any future updates will be listed below
-
Authors
Imai, Takeharu
Tanaka, Yoshihiro https://orcid.org/0000-0002-0300-7924
Sato, Yuta
Mase, Junichi
Suetsugu, Tomonari
Fukada, Masahiro
Yasufuku, Itaru
Iwata, Yoshinori
Imai, Hisashi
Okumura, Naoki
Matsuhashi, Nobuhisa
Takahashi, Takao
Yoshida, Kazuhiro
- License Information
-
More Information
Article History
Received: 14 December 2020
Accepted: 22 February 2021
First Online: 27 March 2021
Declarations
:
: Dr. Yoshida reports receipt of grants, personal fees, and non-financial support from EA Pharma Co., Ltd., Sanofi, Yakult Honsha Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., Merck Serono Co., Ltd., and Novartis Pharma K.K.; and grants from Kyowa Hakko Kirin Co., Ltd. outside of the submitted work. Dr. Tanaka reports receipt of grants from Daiichi Sankyo Co., Ltd. outside of the submitted work. Other authors have no conflict of interest to disclose. The funding source had no role in the design, practice, or analysis of this study.
: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from the patient for being included in the study.
